Title:
TRIAZASPIRO LPAR1 ANTAGONIST AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/109878
Kind Code:
A1
Abstract:
A compound effectively antagonizing LPAR1. The compound is a compound represented by the following formula, or is a stereoisomer, a hydrate, a solvate, a pharmaceutically acceptable salt, or a prodrug of the compound represented by the following formula.
Inventors:
ZHANG XUEJUN (CN)
ZANG YANG (CN)
YANG HUI (CN)
LEI SIJUN (CN)
WANG HONGQIANG (CN)
YANG JUN (CN)
LI LIE (CN)
CHANG SHAOHUA (CN)
ZANG YANG (CN)
YANG HUI (CN)
LEI SIJUN (CN)
WANG HONGQIANG (CN)
YANG JUN (CN)
LI LIE (CN)
CHANG SHAOHUA (CN)
Application Number:
PCT/CN2022/139166
Publication Date:
June 22, 2023
Filing Date:
December 15, 2022
Export Citation:
Assignee:
WUHAN HUMANWELL INNOVATIVE DRUG RES AND DEVELOPMENT CENTER LIMITED COMPANY (CN)
International Classes:
C07D249/06; A61K31/4192; A61K31/4439; A61P11/00; A61P35/00; C07D401/04
Domestic Patent References:
| WO2020147739A1 | 2020-07-23 | |||
| WO2022100623A1 | 2022-05-19 | |||
| WO2022100624A1 | 2022-05-19 | |||
| WO2022100625A1 | 2022-05-19 | |||
| WO2022232459A1 | 2022-11-03 |
Foreign References:
| CN109963843A | 2019-07-02 |
Attorney, Agent or Firm:
ZHIFAN & PARTNERS (CN)
Download PDF:
Previous Patent: PRO-XYLANE, PRODUCTION METHOD THEREFOR AND USE THEREOF
Next Patent: RADIO FREQUENCY LINK SWITCHING METHOD AND COMMUNICATION DEVICE
Next Patent: RADIO FREQUENCY LINK SWITCHING METHOD AND COMMUNICATION DEVICE